R. Morgan

发表

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.

S. Groshen, Y. Yen, J. Doroshow, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.

J. Doroshow, L. Leong, G. Somlo, 2000, Gynecologic oncology.

High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.

J. Doroshow, L. Leong, S. Akman, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies.

Y. Yen, L. Leong, P. Frankel, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Modulation of 5-fluorouracil with high-dose leucovorin calcium: activity in ovarian cancer and correlation with CA-125 levels.

J. Doroshow, L. Leong, S. Akman, 1995, Gynecologic oncology.

Evaluating the Impact of Pain Management (PM) Education on Physician Practice Patterns—A Continuing Medical Education (CME) Outcomes Study

N. Slatkin, J. Ninnis, M. Rhiner, 2010, Journal of Cancer Education.

Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.

Y. Yen, J. Doroshow, L. Leong, 1998, Cancer research.

Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.

J. Doroshow, L. Leong, G. Somlo, 1999, Gynecologic oncology.

Targeted Agents in Ovarian Cancer

M. Cristea, R. Morgan, TS Kristedja, 2010, Women's health.

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

S. Kane, L. Leong, C. Russell, 2012, Breast Cancer Research and Treatment.

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

Y. Yen, L. Leong, G. Somlo, 2001, Bone Marrow Transplantation.

Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer

S. Neuhausen, L. Leong, S. Wilczynski, 2023, Journal of Ovarian Research.

A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

L. Leong, P. Frankel, M. Cristea, 2012, Cancer Chemotherapy and Pharmacology.

Targeted Agents in Ovarian Cancer

M. Cristea, R. Morgan, TS Kristedja, 2010, Women's health.